Clinical trial / 2017
Moringa oleifera leaf capsules (8 g/day) had no significant effect on glycemic control in therapy-naïve type 2 diabetes patients.
Thirty-two therapy-naïve type 2 diabetes patients were randomized to receive either 8 grams per day of Moringa oleifera (MO) leaf capsules or placebo for 4 weeks. There was no significant difference in FPG and HbA1C between groups, and no adverse effects were observed. The MO leaf group experienced a 5 mmHg reduction in systolic blood pressure compared to baseline, but this change was not statistically significant.
- Study type
- Prospective randomized placebo-controlled study
- Who was studied
- 32 therapy-naïve type 2 diabetes mellitus patients (mean age 55 years, mean HbA1C 7.0%)
- What was measured
- Glucose control (FPG, HbA1C, 9-point plasma glucose) and safety
THE PAPER
Effect of Moringa oleifera Leaf Capsules on Glycemic Control in Therapy-Naïve Type 2 Diabetes Patients: A Randomized Placebo Controlled Study.
Taweerutchana R, Lumlerdkij N, Vannasaeng S, Akarasereenont P, Sriwijitkamol A. Evid Based Complement Alternat Med, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.